Psychiatry

Peter Hauser, M.D.

Selected Publications:

BOOKS:
  1. Brain Imaging in the Affective Disorders. Editor: Peter Hauser, M.D., American Psychiatric Press, Washington, D.C., 1991.
  2. Thyroid Diseases of Infancy and Childhood: Effects on Behavior and Intellectual Development. Editors: Peter Hauser M.D. and Joanne Rovet Ph.D., American Psychiatric Press, Washington, D.C., 1998.
CHAPTERS:
  1. Seeman, M.V. and Hauser, P.:Dopamine receptors, gender and genetics in schizophrenia. In: Schizophrenia: An Integrative View, C.L. Cazzulo and G.Inernizzi (Eds), John Libbey, London, l84-l87, 1985.
  2. Hauser, P.:Magnetic Resonance Imaging in Primary Affective Disorder. In: Brain Imaging in the Affective Disorders, P. Hauser (Ed), American Psychiatric Press, Washington, D.C., 1991.
  3. Pass K.A., Hedden M.B., Morris J.E., Hauser P., Weintraub B.D., Mizewski G.J.: Newborn screening for thyroid resistance: Implications for attention deficit hyperactivity disorder. In: New Horizons in Neonatal Screening, Farriaux and Dhondt; (Eds), Excerpta Medica, Amsterdam-London-New York-Tokyo, 141-144, 1994.
  4. Reed SA, Kling MA, Hauser P.: The Course of Mood Disorders: Adult Developmental and Gender-related Issues. In: Psychiatric Disorders Across the Life Cycle, Paul Ruskin and Richard Sarles; (Eds) (in press.
SCIENTIFIC PUBLICATIONS:
  1. Hauser, P., McGrail, S., Seeman, M.V. and Voineskos, G.: Risk factors in schizophrenia. Perspectives in Psychiatry. 3(6):5-7, l984.
  2. Seeman, M.V. and Hauser. P.: Schizophrenia: The influence of gender on family environment. International Journal of Family Psychiatry. 5(3): 227-32, l984.
  3. Hauser, P. and Seeman, M.V.: Schizophrenia in males versus females: a brief guide to office counselling. Human Sexuality. 19(4): 109-119, l985.
  4. Hauser, P., Finkelberg, F., Pollock, B., McGrail, S., Seeman, M.V. and Voineskos, G.: Risk and protective factors in schizophrenia: clinical and social implications. Modern Medicine of Canada. 40(6): 579-584, l985.
  5. Hauser, P., Pollock, B., Finkelberg, F., McGrail, S., Voineskos, G. and Seeman, M.V.: On sinistrality and sex differences in schizophrenia. American Journal of Psychiatry.142:1228, l985.
  6. Konstantareas, M., Hauser, P., Lennox, C. and Homatidis, S.: Season of birth in infantile autism. Child Psychiatry and Human Development.17(1): 53-65,1986.
  7. Hauser, P., Seeman, M.V., Hood, J. and Hudson, C.: Anomalous motoric lateralization and schizophrenia: clinical implications. Hillside Journal of Psychiatry.10: 16-23, 1988.
  8. De Lisi, L.E., Dauphinais, D. and Hauser, P.: Gender differences in brain development and schizophrenia. Comprehensive Psychiatry.30(3): 197-208, 1989.
  9. Hauser, P., Devinsky, O., De Bellis, M., Theodore, W.H. and Post,R.M.: Benzodiazepine withdrawal delirium with catatonic features: occurence in patients with partial seizure disorders. Archives of Neurology.46: 696-99, 1989.
  10. Hauser, P., Dauphinais D.I., Berrettini, W., De Lisi, L.E. and Post, R.M.: Corpus callosal dimensions measured by magnetic resonance imaging in bipolar affective disorder and schizophrenia. Biologic Psychiatry.26: 659-68, 1989.
  11. Hauser, P., Altshuler, L., Berrettini, W., Dauphinais D., Gelernter, J., and Post, R. M.: Temporal lobe measurement in primary affective disorder by magnetic resonance imaging. Journal of Neuropsychiatry and the Clinical Neurosciences.1: 128-34, 1989.
  12. Usala S. H., Tennyson G. E., Bale A. E., Lash R. W., Gesundheit N., Wondisford F. E., Accili D., Hauser P., Weintraub B. D.: A single base mutation of the c-erbA thyroid hormone receptor in a kindred with generalized thyroid hormone resistance: molecular heterogeneity in two other kindreds. Journal of Clinical Investigation. 85:93-100,1990.
  13. Altshuler L.L., Conrad A., Hauser P., Li X., Guze B.H., Denikoff K., Post R.M.: Temporal lobe volume reduction in bipolar disorder: a preliminary MRI report. Archives of General Psychiatry. 48: 482-3,1991.
  14. Steinfelder H.J., Hauser P., Nakayama Y., McClaskey J.M., Taylor T., Weintraub, B.D., Wondisford, F.E.: Multiple cis-acting elements mediate induction of human TSH ß gene expression by thyrotropin-releasing hormone: potential interaction with a thyroid hormone inhibitory element. Proceedings of the National Academy of Science, USA.88: 3130-3134, April 1991.
  15. Steinfelder H.J., Radovick S., Mroczynski M.A., Hauser P., McClaskey J.M., Weintraub, B.D, Wondisford, F.E.: Role of a pituitary-specific transcription factor (Pit-1/ GHF-1) or a closely related protein in cAMP regulation of human thyrotropin-ß subunit gene expression. Journal of Clinical Investigation, 89: 409-19 February,1992.
  16. Mellman, T. A., Leverich, G., Hauser, P., Kramlinger K., Post, P. M., Uhde, T. W.: Axis II Pathology in panic and affective disorders: relationship to diagnosis, course of illness, and treatment response. Journal of Personality Disorders. 6(1): 53-63, 1992.
  17. Perini G.I., Devinsky O., Hauser P., Chrousos G.P., Gold P.W., Kling M.A.: Effects of carbamazepine on pituitary-adrenal function in healthy volunteers. Journal of Clinical Endocrinology and Metabolism. 74: 406-12, 1992.
  18. Mixson A.J., Parrilla R., Ransom S., Wiggs E., McClasky J., Hauser P., Weintraub B.D.: Correlations of language abnomalities in the ß- thyroid receptor in 13 kindreds with generalized resistance to thyroid hormone: Identification of four novel mutations. Journal of Clinical Endocrinology and Metabolism. 75:1039-45,1992.
  19. Hauser P., Zametkin A.J., Martinez P., Vitiello B., Matochik J.A., Mixson A.J., Weintraub B.D.: Attention-deficit hyperactivity disorder in people with generalized resistance to thyroid hormone. New England Journal of Medicine. 328:997-1001, 1993. (This article was translated into French and published as Hyperactivite avec deficit de l' attention et resistance generalisee aux hormones thyroidiennes. Le Journal de Medecine. 273: 23-28, 1993.
  20. Mixson A.J., Hauser P., Tennyson G., Renault J.C., Bodenner D.L., Weintraub B.D.: Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone. Journal of Clinical Investigation. 91:2296-2300, 1993.
  21. Hauser P., Zametkin A.J., Weintraub B.D.:Attention-deficit hyperactivity disorder. New England Journal of Medicine. 329: 967,1993.
  22. Hauser P.: Resistance to thyroid hormone and the ß thyroid receptor gene: implications for behavioral and brain research. Psychoneuroendocrinology. 19:iii-vii,1994.
  23. Hauser P., Zametkin A.J., Martinez P., Vitiello B., Matochik J.A., Mixson A.J.,Weintraub B.D.: ADHD and the thyroid controversy. Journal of the American Academy of Child and Adolescent Psychiatry. 33: 756-7, 1994.
  24. Leonard C.M., Martinez P., Weintraub B.D., Hauser P.: Magnetic resonance imaging of cerebral anomalies in subjects with resistance to thyroid hormone. American Journal of Medical Genetics (Neuropsychiatric Genetics). 60: 238-243, 1995.
  25. Altshuler L.L., Curran J.G., Hauser P., Mintz J., Conrad A., Denikoff K., Post R.M.: T2 hyperintensities in bipolar disorder: MRI comparison and literature meta-analysis. American Journal of Psychiatry, 152: 1139-1144, 1995.
  26. Mizewski G.J., Morris J.E., Hauser P., Weintraub B.D., Pass K.A..: A strategy for newborn screening for resistance to thyroid hormone: relevance to attention deficit hyperactivity disorder. Screening, 4:61-70, 1995.
  27. Brucker-Davis F., Skarulis M.C., Grace M.B., Hauser P., Wiggs E., Weintraub B.D.: Genetic and clinical features of 42 kindreds with resistance to thyroid hormone: the NIH prospective study. Annals of Internal Medicine, 123:572-583, 1995.
  28. Matochik J.A., Zametkin A.J., Cohen R.M., Hauser P., Weintraub B.D.: Abnormalities in sustained attention and anterior cingulate metabolism in subjects with resistance to thyroid hormone. Brain Research, 723:23-28, 1996.
  29. Hauser P., Solar R., Brucker-Davis F., Weintraub B.D.: Thyroid hormones correlate with symptoms of hyperactivity but not inattention in attention deficit hyperactivity disorder. Psychoneuroendocrinology, 22:107-114, 1997.
  30. Valentine A.D., Meyers C.A., Kling M.A., Richelson E., Hauser P.: Cognitive and affective side effects of alpha interferon therapy. Seminars in Oncology, 25(suppl.1):39-47, 1998.
  31. Licinio, J., Kling M.A., Hauser P.: Cytokines and brain function: relevance to interferon alpha-induced mood and cognitive changes. Seminars in Oncology, 25(suppl.1):30-38, 1998.
  32. Hauser P., McMillin J.M., Bhatara V.S.: Resistance to thyroid hormone: implications for neurodevelopmental research on the effects of thyroid hormone disruptors. Toxicology and Industrial Health, 14:85-101, 1998.
  33. Ruskin P., Reed S., Kumar R., Kling, M.A., Siegel E., Rosen M., Hauser P.: Telecommunications and audio-video technology in the diagnosis of psychiatric illness: reliability and acceptability. Psychiatric Services, 49:1086-88, 1998.
  34. DeVito M., Biegel L., Brouwer A., Browm S., Brucker-Davis F., Cheek A.O., Christensen R., Colborn T., Cooke P., Crissman J., Crofton K., Doerge D., Gray E., Hauser P., et al.: Screening methods for thyroid hormone disruptors. Environmental Health Perspectives,107:407-415, 1999.
  35. Kittur S.D., Hauser P.: Improvement of Sleep and Behavior by Methylphenidate in Alzheimer's Disease. Am J Psychiatry, 156(7) 1116-1117, 1999.
  36. Hauser P., Matochik J.A., Altshuler L.L., Denikoff K., Conrad A., Li X., Post R.M.: MRI- based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. Journal of Affective Disorders, 60:25-32, 2000.
  37. Hauser P., Soler R., Reed S., Kane R., Gulati M., Khosla J., Kling M.A., Valentine A.D., Meyers C.A.: Prophylactic treatment of depression induced by interferon-. Psychosomatics, 41(5):439-441, 2000.
  38. Regenold W.T., Kling M.A., Hauser P.: Elevated sorbitol concentrations in the cerebrospinal fluid of patients with mood disorders. Psychoneuroendocrinology, 25(6):593-606, 2000.
  39. Ali S.O., Denicoff K.D., Altshuler L.L. Hauser P., Li X., Conrad A.J., Mirsky A.F., Smith-Jackson E.E., Post R.M.: A preliminary study of the relation of neuropsychological performance to neuroanatomic structures in bipolar disorder. Neuropsychiatry Neuropsychol Behav Neurol., 13(1):20-8, 2000.
  40. Phillips S.A., Rotman-Pikielny P., Lazar J., Ando S., Hauser P., Skarulis M.C., Brucker-Davis F., Yen P.M. Extreme thyroid hormone resistance in a patient with a novel truncated TR mutant. J Clin Endocrinol Metab. 86(11):5142-7, 2001.
  41. Ali S.O., Denicoff K.D., Altshuler L.L., Hauser P., Li X., Conrad A.J., Smith-Jackson E.E., Leverich G.S., Post R.M.: Relationship between Prior Course of Illness and Neuroanatomic Structures in Bipolar Disorder: A Preliminary Study. Neuropsychiatry Neuropsychol Behav Neurol. 14(4):227-32, 2001.
  42. Capuron L, Hauser P, Hinze-Selch D., Miller A.H., Neveu P.: Treatment of Cytokine Induced Depression. Brain Behavior & Immunity, (in press).
  43. Hauser, P., Khosla, J., Aurora, H., Laurin, J., Kling, M.A., Hill, J., Gulati, M., Thornton, A.J., Schultz, R.L., Valentine, A.D., Meyers, C.A., Howell, C.D. A prospective study of the incidence and open label treatment of interferon-induced major depressive disorder in patients with hepatitis c. Molecular Psychiatry (in press).
  44. Ruskin P., Silver-Aylaian M., Kling M., Reed S., Bradham D., Hebel J., Barrett D., Knowles F., Hauser P. Efficacy of telepsychiatry in the treatment of depression. (under revision, Am J Psychiatry).
  45. Regenold, W., Kling, M., Hauser, P. Abnormal Glucose Metabolism in Mood and Psychotic Disorders Evidenced by Elevated Postmortem Brain Sorbitol Concentration. (submitted)
  46. Dobscha, S., Anderson, T., Hoffman, W., Winterbottom, L., Turner, E., Snodgrass, L., Hauser, P. A multifaceted intervention to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA hospital. (submitted)
Faculty Page Research Projects


OHSU | Faculty | Training | Grand Rounds | Psychiatry